Regulatory Updates
Aug 23, 2026•1 min read
Label Mixup Recall: Potential Mislabeling of Famotidine 20 mg Tablets
The FDA reports a labeling mixup where Famotidine 20 mg tablets may be mislabeled as Carvedilol Phosphate ER capsules, along with other products.
1
Regulatory Updates
Aug 23, 2026•1 min read
FDA Recalls Product Over Sterility Concerns Due to GMP Violations
The FDA has initiated a recall after an inspection revealed GMP violations that could compromise product sterility.
1
Regulatory Updates
Aug 23, 2026•1 min read
FDA Recalls Product Due to Lack of Assurance of Sterility
The FDA has issued a recall for a product because sterility could not be assured.
1